Wang Shirley V, Rogers James R, Jin Yinzhu, Bates David W, Fischer Michael A
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Division of General Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
J Am Med Inform Assoc. 2017 Mar 1;24(2):339-344. doi: 10.1093/jamia/ocw082.
Practice guidelines recommend anticoagulation therapy for patients with atrial fibrillation (AF) who have other risk factors putting them at an elevated risk of stroke. These patients remain undertreated, but, with increasing use of electronic healthcare records (EHRs), it may be possible to identify candidates for treatment.
To test algorithms for identifying AF patients who also have known risk factors for stroke and major bleeding using EHR data.
We evaluated the performance of algorithms using EHR data from the Partners Healthcare System at identifying AF patients and 16 additional conditions that are risk factors in the CHA 2 DS 2 -VASc and HAS-BLED risk scores for stroke and major bleeding. Algorithms were based on information contained in problem lists, billing codes, laboratory data, prescription data, vital status, and clinical notes. The performance of candidate algorithms in 1000 bootstrap resamples was compared to a gold standard of manual chart review by experienced resident physicians.
: Physicians reviewed 480 patient charts. For 11 conditions, the median positive predictive value (PPV) of the EHR-derived algorithms was greater than 0.90. Although the PPV for some risk factors was poor, the median PPV for identifying patients with a CHA 2 DS 2 -VASc score ≥2 or a HAS-BLED score ≥3 was 1.00 and 0.92, respectively.
We developed and tested a set of algorithms to identify AF patients and known risk factors for stroke and major bleeding using EHR data. Algorithms such as these can be built into EHR systems to facilitate informed decision making and help shift population health management efforts towards patients with the greatest need.
实践指南建议,对于患有心房颤动(AF)且伴有其他增加中风风险因素的患者,应进行抗凝治疗。这些患者的治疗仍不充分,但随着电子健康记录(EHR)使用的增加,有可能识别出适合治疗的患者。
使用EHR数据测试用于识别同时患有已知中风和大出血风险因素的AF患者的算法。
我们使用来自Partners医疗保健系统的EHR数据评估算法在识别AF患者以及另外16种在中风和大出血的CHA₂DS₂-VASc和HAS-BLED风险评分中作为风险因素的疾病方面的性能。算法基于问题列表、计费代码、实验室数据、处方数据、生命状态和临床记录中包含的信息。将1000次自助重采样中候选算法的性能与经验丰富的住院医师进行手动图表审查的金标准进行比较。
医生审查了480份患者病历。对于11种疾病,EHR衍生算法的中位阳性预测值(PPV)大于0.90。尽管某些风险因素的PPV较差,但识别CHA₂DS₂-VASc评分≥2或HAS-BLED评分≥3的患者的中位PPV分别为1.00和0.92。
我们开发并测试了一组算法,以使用EHR数据识别AF患者以及已知的中风和大出血风险因素。这样的算法可以内置到EHR系统中,以促进明智的决策,并有助于将人群健康管理工作转向最需要的患者。